Latest News for 09/2018
28 Sep 2017
* EVOTEC INVESTS in Exscientia to advance AI-driven DRUG DISCOVERY Evotec AG and Exscientia Ltd - a company ‘spun out’ from research at the University of Dundee - today announced that Evotec has made a € 15 m investment to take a minority stake in Exscientia.
05 Jul 2017
Pre-clinical collaboration focused on up to 10 targets nominated by GSK
20 Jun 2017
Dundee University spin-out company, Exscientia, won two awards at the Chemistry Means Business 2017 Awards, hosted by the UK Royal Society of Chemistry in Manchester last week. Its Chief Executive Officer Andrew Hopkins has been named Chemistry World ‘Entrepreneur of the Year’ and Chief Technology Officer Jérémy Besnard won the ‘Rising Star in Industry’ Award for their work at Exscientia, an innovative company at the forefront of Artificial Intelligence (AI)-driven drug discovery.
19 May 2017
Exscientia, an innovative company at the forefront of Artificial Intelligence (AI)-driven drug discovery, is pleased to announce that it has agreed a strategic research collaboration, and licence option agreement with Sanofi in the high-interest area of metabolic disease. Exscientia is a spin-out company from the School.
16 Nov 2016
The University of Dundee announced today that it is a Grand Challenges Explorations winner, an initiative funded by the Bill & Melinda Gates Foundation. The project will enable a unique collaboration bringing together expertise at Dundee in male fertility and drug discovery to help identify possible new male contraceptive drugs.
07 Mar 2016
The Royal Society of Edinburgh has announced today that four people from the University of Dundee have been elected as Fellows of the RSE, three of whom are from the Schools of Life Sciences. The new Fellows from the University are: · Wendy Alexander, Vice-Principal (International) · Paul Birch, Professor of Plant Pathology and Deputy Head of the Division of Plant Sciences
20 Jan 2016
The Universities of Dundee, Oxford and Edinburgh have announced the formation of the Phenotypic Discovery Initiative (PDi) with Janssen Pharmaceutica N.V. the first industry partner joining the initiative. A phenotype is one or more observable features or traits that report changes in a biological system or its reaction its environment. Phenotypic screening is the systematic identification of agents (such as small molecules, biological molecules or genetic mutations) that alter a phenotype.
01 Apr 2015
Professor Andrew Hopkins, of the College of Life Sciences at the University of Dundee, has been named Commercial Innovator of the Year at the BBSRC (Biotechnology and Biological Sciences Research Council) 2015 Innovator of the Year Awards. Professor Hopkins won the award at a ceremony in London last night (March 31st). He was nominated for his pioneering work in algorithmic drug design.
06 Feb 2015
Professor Andrew Hopkins, of the College of Life Sciences at the University of Dundee, has been named one of this year’s winners at the prestigious Scottish Enterprise Life Sciences Awards. At a ceremony in Edinburgh last night Professor Hopkins was handed the award for Life Sciences Entrepreneurial Business Leadership. Andrew is the founder and CEO of ex scientia, a University of Dundee spin-out company which is pioneering medicines tailored to polypharmacology for a wide range of human diseases where improved efficacy is required.
18 Nov 2014
Life Sciences spin-out company ex scientia has been named Young Business of the Year at the second annual Courier Business Awards which were held at Fairmont St Andrews on November 14. 600 local business leaders from Tayside, Fife and Perthshire attended the ceremony at which a total of 14 awards were handed out by host and television comedian Hugh Dennis, including 12 sector-specific prizes covering all aspects of the diverse economy of east central Scotland.